This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lucantoni, R. Articles by Di Blasio, A. M. Search for Related Content PubMed PubMed Citation Articles by Lucantoni, R. Articles by Di Blasio, A. M.

The A19G Polymorphism in the 5' Untranslated Region of the Human Obese Gene Does Not Affect Leptin Levels in Severely Obese Patients

Division of Endocrinology and Metabolic Diseases (R.L., M.E.B., G.S., A.M., G.C., A.L.), Laboratory of Clinical Chemistry (C.D.M.), Ospedale San Giuseppe, Istituto Auxologico Italiano, 28921 Verbania; and Molecular Biology Laboratory (E.P., A.M.D.B.), Istituto Auxologico Italiano Milano, 20135 Milano, Italy

Address correspondence and requests for reprints to: Anna Maria Di Blasio, M.D., Molecular Biology Laboratory, Istituto Auxologico Italiano, V.le Monte Nero 32, 20135 Milano, Italy. E-mail: biomol{at}auxologico.it

Recently, the presence of different polymorphisms in the regulatory region of the ob gene has been associated with variations in leptin levels. However, the results of these studies are still contradictory. The aim of the present investigation was to evaluate the presence of the A19G polymorphism in an Italian population of obese patients and to verify its association with leptin levels and anthropometric, metabolic, and clinical parameters. Two hundred five obese patients [body mass index (BMI) > 36 kg/m²; 135 women and 70 men; mean age, 46.9 ± 14.23 yr] were screened for presence of the polymorphism; 61 normal-weight controls (mean BMI, 21.05 kg/m²; 53 women, 8 men) were also screened to compare polymorphism frequency. For obese patients, BMI, waist-to-hip ratio, resting energy expenditure, body composition, fasting leptin, total cholesterol, high-density lipoproteins, triglycerides, and caloric intake were determined. Genotype frequencies in obese and control subjects were compared using the contingency table chi-square test; in obese subjects an ANOVA was performed to evaluate association between the polymorphism and several clinical parameters. No significant differences in genotype distribution between control and obese subjects were found. No significant correlations were found between this polymorphism and serum leptin levels and the other parameters considered. These findings confirm the results obtained in both a Finnish and a French population; taken together, these observations might rule out a significant role for the A19->G polymorphism in the regulation of leptin levels and other clinical, anthropometric, and metabolic parameters.

This article has been cited by other articles:

				V. Paracchini, P. Pedotti, and E. Taioli Genetics of Leptin and Obesity: A HuGE Review Am. J. Epidemiol., July 15, 2005; 162(2): 101 - 114. [Abstract] [Full Text] [PDF]